Researchers at the Mayo Clinic and colleagues have demonstrated that an artificial intelligence (AI) tool can analyze routine histopathological slides to help physicians classify meningiomas, the most common primary brain tumor in adults, and better understand a patient's risk of tumor recurrence.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Researchers at the Mayo Clinic and colleagues have demonstrated that an artificial intelligence (AI) tool can analyze routine histopathological slides to help physicians classify meningiomas, the most common primary brain tumor in adults, and better understand a patient's risk of tumor recurrence.